Date | Insider | Price | Amount |
---|---|---|---|
11-18-2019 Insider Buy |
Jason P. Rhodes Director |
$13.61 CAGR » |
$14,971,000.00 1,100,000 shares |
11-18-2019 Insider Buy |
Omega Fund IV, L.P. >10% Owner |
$13.61 CAGR » |
$2,994,200.00 220,000 shares |
7-24-2018 Insider Buy |
Capital Fund Cooperatief U.A. Forbion III >10% Owner |
$15.00 CAGR » |
$1,999,995.00 133,333 shares |
7-24-2018 Insider Buy |
Joseph P. Slattery Director |
$15.00 CAGR » |
$100,005.00 6,667 shares |
7-24-2018 Insider Buy |
Hugo Alexander Slootweg Director and >10% Owner |
$15.00 CAGR » |
$1,999,995.00 133,333 shares |
7-24-2018 Insider Buy |
Bain Capital Life Sciences Investors, LLC >10% Owner |
$15.00 CAGR » |
$7,500,000.00 500,000 shares |
7-24-2018 Insider Buy |
Omega Fund IV, L.P. >10% Owner |
$15.00 CAGR » |
$4,000,005.00 266,667 shares |
Also See: Institutional Holders of REPL
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 11/19/2019 | |
End date: | 04/26/2024 | |
Start price/share: | $12.50 | |
End price/share: | $6.42 | |
Dividends collected/share: | $0.00 | |
Total return: | -48.64% | |
Average Annual Total Return: | -13.95% | |
Starting investment: | $10,000.00 | |
Ending investment: | $5,135.47 | |
Years: | 4.44 |
REPL Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent REPL insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding REPL
Free REPL Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the REPL Insider Buying occurred are:
AGIO Insider Buying |